TSX-049 clinical trial
Latest Information Update: 02 Dec 2019
At a glance
- Drugs Testosterone undecanoate (Primary)
- Indications Hypogonadism
- Focus Adverse reactions
- Sponsors TesoRx
Most Recent Events
- 02 Dec 2019 New trial record
- 26 Nov 2019 According to TesoRx media release, human clinical trials to be initiated by Q2 2020 with potential U.S. Food and Drug Administration approval as soon as 2023